Viewing nowTelmira Tablet 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 201502987 · Approved 2015.05.19 · Insurance code 657805580
Treatment of essential hypertension and prevention of cardiovascular disease
This drug effectively controls blood pressure in patients with essential hypertension, reducing the burden on the cardiovascular system. Additionally, it helps reduce the risk of myocardial infarction, stroke, and death from cardiovascular diseases in patients aged 55 and older who are at high risk. It is particularly beneficial for patients with a history of coronary artery disease, peripheral artery disease, stroke, or diabetes-related end-organ damage. This medication protects cardiovascular health in these patients and contributes to improved overall survival.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. When this medicine is administered in combination with thiazide diuretics such as hydrochlorothiazide, it has an additional blood pressure-lowering effect. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water, and it may be taken regardless of meals. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This drug may cause serious harm, especially to the fetus and newborn, during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with a known allergy to this drug, those who are pregnant or breastfeeding, those with severely impaired liver function, or those with a history of hereditary angioedema should not take this medication. Patients with mild liver impairment, elderly patients, those with hyperkalemia, and those with heart or kidney diseases should use this drug cautiously and should have their conditions monitored regularly by a physician. During treatment, blood pressure, kidney function, and blood potassium levels should be monitored regularly for any abnormalities. When combined with other antihypertensive medications, there may be an increased risk of hypotension, worsening kidney function, and hyperkalemia, so consultation with a physician is necessary. If blood pressure drops too low or symptoms of dizziness or fainting occur, immediate medical attention must be sought for appropriate treatment. This drug contains sorbitol and is unsuitable for patients with fructose intolerance. Caution is needed when driving or operating machinery as dizziness or fainting may occur. In case of overdose, symptoms such as hypotension, abnormal heart rate, and worsening kidney function may arise, necessitating an immediate visit to a medical facility. It is not recommended for children and adolescents under 18 years due to insufficient evidence of safety and efficacy. Store out of reach of children and do not transfer to other containers during treatment.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a closed container. Additionally, it is best to store the medication at room temperature between 1 degree and 30 degrees Celsius, avoiding extremely hot or cold locations.
White or off-white, convex oval tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.